semaglutide arrhythmia Subepicardial adipose tissue as a modulator of arrhythmias For patients with obesity and

Flushing and nausea were the most common adverse events reported in both studies and no clinically significant changes in vital signs, laboratory tests, ECGs, or physical exams were observed

The entire statistical analysis plan was repeated in subjects treated with ALCAR 1.5 g/day and their matched controls as a secondary exploratory analysis

Since most people who take GLP-1 drugs eat less, this may affect diet quality and potentially lead to nutritional deficiencies

Metabolic multimorbidity was defined as the coexistence of two or more metabolic diseases, including diabetes, hypertension, dyslipidemia, and hyperuricaemia

Additionally, individuals using anabolic steroids non-medically are often pursuing body composition goals that may conflict with the weight-loss effects of tirzepatide